Hydrogels, versatile crosslinked polymer networks capable of absorbing vast amounts of water, are at the forefront of innovation in biomedical applications, from drug delivery systems to tissue engineering scaffolds. Central to their development is the ability to precisely control network architecture and responsiveness. N-(Methoxymethyl)acrylamide (NMMA), a specialized functional monomer, plays a pivotal role in this field, enabling the creation of advanced hydrogels with tailored properties.
NMMA's unique characteristic lies in its latent crosslinking capability. During the initial polymerization process, NMMA units are incorporated into polymer chains. Subsequently, under specific stimuli such as heat or an acidic environment, the methoxymethyl group activates, facilitating crosslinking between polymer chains. This self-crosslinking mechanism is highly advantageous for hydrogel synthesis, as it can streamline the manufacturing process and allow for the formation of stable, three-dimensional networks without the need for separate, potentially cytotoxic crosslinking agents. For researchers and product developers seeking to buy advanced monomers, NMMA offers a pathway to safer and more efficient hydrogel formulations.
The ability to control the degree of crosslinking through NMMA is critical for tuning hydrogel properties like swelling ratio, mechanical strength, and drug release kinetics. By adjusting the concentration of NMMA in the polymer formulation, manufacturers can engineer hydrogels with precise water absorption capacities and controlled release profiles, essential for targeted drug delivery systems. Furthermore, NMMA can be copolymerized with other stimuli-responsive monomers (e.g., those sensitive to temperature or pH) to create 'smart' hydrogels that respond dynamically to their environment. This makes them ideal for advanced applications in regenerative medicine and biosensing. When sourcing NMMA, understanding its CAS number (3644-11-9) and purity specifications from reliable manufacturers is key to successful hydrogel design.
As a supplier of high-quality NMMA, we are dedicated to supporting advancements in biomaterials science. Our commitment to providing pure, reliable monomers ensures that researchers and manufacturers can develop next-generation hydrogels with predictable performance and enhanced biocompatibility. We encourage you to consider NMMA for your next project in hydrogel development, whether for pharmaceutical delivery, wound care, or tissue engineering applications.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.